LABISAN PROTECTIVE ROSÉ Trademark

Trademark Overview

On Monday, December 10, 2018, a trademark application was filed for LABISAN PROTECTIVE ROSÉ with the United States Patent and Trademark Office. The USPTO has given the LABISAN PROTECTIVE ROSÉ trademark a serial number of 79262683. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 29, 2020. This trademark is owned by Lupuca Pharma GmbH. The LABISAN PROTECTIVE ROSÉ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and medical preparations for the prevention of cold sores, adapted for medical use
labisan protective rosÉ

General Information

Serial Number79262683
Word MarkLABISAN PROTECTIVE ROSÉ
Filing DateMonday, December 10, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, October 29, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedThe color(s) dark blue and pink is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized wording "LABISAN" in dark blue with a design of pink lips with a transparent white center superimposed under the top half of the "BI". The dot in the "I" is in pink. To the top right of the wording "LABISAN" is the wording "PROTECTIVE ROSE" stacked in stylized pink font.
Goods and ServicesPharmaceuticals and medical preparations for the prevention of cold sores, adapted for medical use
Translation of Words in MarkThe wording "Labisan" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLupuca Pharma GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAT

Trademark Events

Event DateEvent Description
Tuesday, November 23, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 29, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 29, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, April 18, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, October 29, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, October 29, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, April 17, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, April 17, 2020FINAL REFUSAL E-MAILED
Friday, April 17, 2020FINAL REFUSAL WRITTEN
Friday, March 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 6, 2020ASSIGNED TO LIE
Monday, March 2, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 1, 2019CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, September 27, 2019REFUSAL PROCESSED BY IB
Thursday, September 19, 2019CORRECTION TRANSACTION RECEIVED FROM IB
Friday, September 6, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 6, 2019REFUSAL PROCESSED BY MPU
Friday, August 23, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 22, 2019NON-FINAL ACTION WRITTEN
Wednesday, August 14, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, July 23, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 22, 2019NON-FINAL ACTION WRITTEN
Friday, July 19, 2019APPLICATION FILING RECEIPT MAILED
Monday, July 15, 2019ASSIGNED TO EXAMINER
Monday, July 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 11, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

protective labisan medical sores adapted cold prevention preparations pharmaceuticals